Sarepta Therapeutics Inc (NASDAQ:SRPT)

91.65
Delayed Data
As of May 25
 +1.66 / +1.84%
Today’s Change
28.82
Today|||52-Week Range
95.67
+64.72%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$6.1B

Company Description

Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. It focuses on the development of its potentially disease-modifying DMD drug candidates. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Contact Information

Sarepta Therapeutics, Inc.
215 First Street
Cambridge Massachusetts 02142
P:(857) 242-4000
Investor Relations:
(617) 274-4052

Employees

Shareholders

Individual stakeholders6.43%
Mutual fund holders53.83%
Other institutional35.62%

Top Executives

Douglas S. IngramPresident, Chief Executive Officer & Director
Sandesh MahatmeExecutive VP, Chief Financial & Business Officer
Catherine Stehman BreenChief Medical Officer
Guriqbal S. BasiChief Scientific Officer
TY HowtonSecretary, Senior Vice President & General Counsel